MX2009012485A - Formulacion oral de nicotina amortiguada con aminoacidos. - Google Patents

Formulacion oral de nicotina amortiguada con aminoacidos.

Info

Publication number
MX2009012485A
MX2009012485A MX2009012485A MX2009012485A MX2009012485A MX 2009012485 A MX2009012485 A MX 2009012485A MX 2009012485 A MX2009012485 A MX 2009012485A MX 2009012485 A MX2009012485 A MX 2009012485A MX 2009012485 A MX2009012485 A MX 2009012485A
Authority
MX
Mexico
Prior art keywords
nicotine
amino acid
oral
disease
oral formulation
Prior art date
Application number
MX2009012485A
Other languages
English (en)
Inventor
Sven-Boerje Andersson
Andreas Hugerth
Roland Olsson
Fredrik Nicklasson
Bengt Bosson
Gunnar Bergengren
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of MX2009012485A publication Critical patent/MX2009012485A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/14—Chewing gum characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Una formulación farmacéutica oral para administrar nicotina en cualquier forma a un sujeto mediante absorción transmucosal en la cavidad bucal; la formulación comprende nicotina en cualquier forma, en donde la formulación oral se amortigua con por lo menos un aminoácido, preferentemente, por lo menos un aminoácido endógeno; también se contempla un método para la administración oral de nicotina en cualquier forma, un método para la reducción de la urgencia de fumar o usar tabaco, así como métodos para elaborar la formulación oral, el uso de la formulación oral para absorción transmucosal de nicotina en la cavidad bucal de un sujeto, y el uso de nicotina para la elaboración de una formulación oral como se indica en la presente para el tratamiento de una enfermedad seleccionada del grupo que comprende dependencia del tabaco o nicotina, enfermedad de Alzheimer, enfermedad de Crohn, enfermedad de Parkinson, síndrome de Tourette, colitis ulcerosa y control del aumento de peso después de dejar de fumar.
MX2009012485A 2007-05-16 2008-04-21 Formulacion oral de nicotina amortiguada con aminoacidos. MX2009012485A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0701178 2007-05-16
PCT/SE2008/000277 WO2008140371A1 (en) 2007-05-16 2008-04-21 Oral nicotine formulation buffered with amino acid

Publications (1)

Publication Number Publication Date
MX2009012485A true MX2009012485A (es) 2009-12-02

Family

ID=40002443

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012485A MX2009012485A (es) 2007-05-16 2008-04-21 Formulacion oral de nicotina amortiguada con aminoacidos.

Country Status (14)

Country Link
US (1) US20080286340A1 (es)
EP (1) EP2152313B1 (es)
JP (1) JP2010526875A (es)
KR (1) KR20100017820A (es)
CN (1) CN101795710A (es)
AR (1) AR066584A1 (es)
AU (1) AU2008251095B2 (es)
BR (1) BRPI0811110A2 (es)
CA (1) CA2685452A1 (es)
MX (1) MX2009012485A (es)
NZ (1) NZ580732A (es)
RU (1) RU2465904C2 (es)
WO (1) WO2008140371A1 (es)
ZA (1) ZA200908960B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103099308A (zh) * 2012-11-13 2013-05-15 苏州谷力生物科技有限公司 一种改性糊精烟用保润剂的制备方法

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
RU2351315C2 (ru) * 2003-07-24 2009-04-10 Смитклайн Бичам Корпорейшн Пленки, растворяющиеся в полости рта
US20160345631A1 (en) 2005-07-19 2016-12-01 James Monsees Portable devices for generating an inhalable vapor
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
EP2197430A2 (en) * 2007-09-18 2010-06-23 NicoNovum AB Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
CN101842085B (zh) * 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
AR071420A1 (es) 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
SG171870A1 (en) * 2009-02-11 2011-07-28 Heglund A S A composition for buccal absorption of nicotine for the purpose of smoking cessation
US20100226904A1 (en) * 2009-03-05 2010-09-09 Hero Nutritionals, LLC Organic chewable supplement
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070301A1 (en) * 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US8313768B2 (en) * 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US10327467B2 (en) 2010-04-14 2019-06-25 Altria Client Services Llc Preformed smokeless tobacco product
KR20130067255A (ko) * 2010-04-27 2013-06-21 노파르티스 아게 경구 투여 형태
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CA2794420A1 (en) * 2010-05-13 2011-12-01 Astrazeneca Ab Injectable emulsion of sedative hypnotic agent
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN102511921B (zh) * 2011-12-30 2014-02-26 华宝食用香精香料（上海）有限公司 一种膜状口含烟的制备方法
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US10799451B2 (en) * 2012-03-27 2020-10-13 Nicoccino Ab Nicotine formulation
EP2830589B1 (en) * 2012-03-27 2019-02-13 Nicoccino Ab Nicotine formulation
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
CA2898729C (en) * 2012-11-14 2018-05-08 Abon Pharmaceuticals, Llc Oral transmucosal drug delivery system
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US10653180B2 (en) 2013-06-14 2020-05-19 Juul Labs, Inc. Multiple heating elements with separate vaporizable materials in an electric vaporization device
FR3005262A1 (fr) * 2013-05-02 2014-11-07 Philippe Gorny Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide.
KR20230013165A (ko) 2013-05-06 2023-01-26 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
CA2932464C (en) 2013-12-05 2023-01-03 Pax Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
FI3491948T4 (fi) 2013-12-23 2024-05-06 Juul Labs International Inc Höyrystyslaitejärjestelmiä
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
CN106068120B (zh) 2014-01-10 2021-03-23 强生消费者公司 使用射频和有损耗的包衣粒子制造片剂的方法
CN103734904B (zh) * 2014-01-21 2016-01-20 江苏中烟工业有限责任公司 一种滋阴降火型烟草口腔喷剂及其制备方法
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN103815542B (zh) * 2014-02-21 2016-09-21 湖北中烟工业有限责任公司 四层烟用水胶囊及其制备方法
JP6672258B2 (ja) * 2014-04-08 2020-03-25 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム ニコチン製剤及びその作製方法
US11478021B2 (en) 2014-05-16 2022-10-25 Juul Labs, Inc. Systems and methods for aerosolizing a vaporizable material
CN103948164B (zh) * 2014-05-19 2016-08-24 川渝中烟工业有限责任公司 口含烟提取液及其制备方法和口含烟
CN104082851A (zh) * 2014-07-08 2014-10-08 山东津美生物科技有限公司 烟草粘合剂及其制备方法与应用
CN104068465B (zh) * 2014-07-08 2016-02-03 川渝中烟工业有限责任公司 浓香型口含烟的制备方法
EP3199039B1 (en) * 2014-10-24 2020-12-09 Japan Tobacco Inc. Oral tobacco composition and production method thereof
EP3821735A1 (en) 2014-12-05 2021-05-19 Juul Labs, Inc. Calibrated dose control
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
JP6324349B2 (ja) * 2015-06-26 2018-05-16 長谷川香料株式会社 塩味増強剤
CN104970445B (zh) * 2015-07-21 2017-11-07 中国烟草总公司广东省公司 一种缓释型气雾口香烟
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
CN105230940B (zh) * 2015-10-20 2021-06-22 贵州中烟工业有限责任公司 一种功能性硬质糖果及其制备方法
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
SG11201806801VA (en) 2016-02-11 2018-09-27 Juul Labs Inc Securely attaching cartridges for vaporizer devices
EP3413960B1 (en) 2016-02-11 2021-03-31 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
EP3445344B1 (en) 2016-04-21 2020-08-19 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
SG11201809594WA (en) * 2016-06-30 2018-11-29 Philip Morris Products Sa Nicotine particles and compositions
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
US20180103681A1 (en) * 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for increasing stability of the pre-vapor formulation of an e-vaping device
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CA3057078A1 (en) * 2017-03-20 2018-09-27 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
EP3634387B1 (en) 2017-05-22 2024-01-17 Johnson & Johnson Consumer Inc. Lozenge dosage form
CA3068558A1 (en) * 2017-06-26 2019-01-03 Nude Nicotine, Inc. Nicotine salts and methods of making and using same
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
GB2569940B (en) * 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
EP3720499A1 (en) * 2017-12-08 2020-10-14 Fertin Pharma A/S Nicotine mouth spray
CA3085063A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
AU2018378648B2 (en) * 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
JP7182639B2 (ja) * 2018-03-01 2022-12-02 エルテーエス ローマン テラピー－ジステーメ アーゲー テオブロミンフリーのココアを含有する経口剤形
US20210255202A1 (en) 2018-06-13 2021-08-19 Michael R. D'Andrea Methods and dosing regimens for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild congnitive impairment
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
SE544446C2 (en) * 2019-02-01 2022-05-31 Swedish Match North Europe Ab AN ORAL NICOTINE PRODUCT COMPRISING A pH ADJUSTING AGENT
CN110384700A (zh) * 2019-09-03 2019-10-29 云南喜科科技有限公司 一种合成尼古丁的组合物
JP2023504756A (ja) 2019-12-09 2023-02-06 ニコベンチャーズ トレーディング リミテッド カンナビノイドを含む口腔用製品
US11541004B2 (en) 2020-06-10 2023-01-03 Howard University Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
US11911375B2 (en) * 2020-11-16 2024-02-27 Fertin Pharma A/S Solid oral nicotine formulation
CN112841709B (zh) * 2021-01-20 2022-11-25 深圳市艾普生物科技有限公司 一种尼古丁盐的制备方法及应用
DE102021105268A1 (de) 2021-03-04 2022-09-08 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
WO2022224200A1 (en) * 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral compositions and methods of manufacture
CA3231103A1 (en) * 2021-10-08 2023-04-13 Venda Porter MALONEY Oral compositions comprising arginine and gelling agent
CN113880802A (zh) * 2021-11-09 2022-01-04 深圳萨特瓦生物科技有限公司 酒石酸-尼古丁盐及其制备方法与应用、无水酒石酸晶体的制备方法
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
JPS55122709A (en) * 1979-03-13 1980-09-20 Asama Kasei Kk Stench remover from mouth
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5009893A (en) * 1989-07-17 1991-04-23 Warner-Lambert Company Breath-freshening edible compositions of methol and a carboxamide
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5165943A (en) * 1991-06-21 1992-11-24 Wm. Wrigley Jr. Company Cooling agent/cyclodextrin complex for improved flavor release
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US5578563A (en) * 1994-08-12 1996-11-26 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
NL1002833C2 (nl) * 1996-04-10 1997-04-03 Gerardus Joannes Emile Maria N Werkwijze, voor duurzame ontwenning van/aan nicotine en andere verslavende producten door toediening van sex steroide voorlopers (precursors), alsmede het gebruik van die voorlopers als medicijn.
EP0803243B1 (en) * 1996-04-24 2003-03-19 Pfizer Inc. Cyclodextrins and phenolic compounds in dental products
US5866179A (en) * 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
EP0906089B1 (en) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Buccal delivery system
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US5885599A (en) * 1996-10-28 1999-03-23 The Procter & Gamble Company Methods and compositions for reducing body odors and excess moisture
US5942214A (en) * 1997-06-09 1999-08-24 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6197288B1 (en) * 1997-10-16 2001-03-06 Bush Boake Allen, Inc. Malodor counteractant compositions and method for preparing and using same
HUP0104503A3 (en) * 1998-11-25 2003-03-28 Procter & Gamble Improved uncomplexed cyclodextrin compositions for odor control
US6680289B1 (en) * 1999-09-02 2004-01-20 The Proctor & Gamble Company Methods, compositions, and articles for odor control
US6497859B1 (en) * 2000-11-17 2002-12-24 Noville Inc. Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
EP1304048B1 (en) * 2001-10-22 2004-09-22 Ivo Pera Composition to reduce or quit smoking addiction
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20040018157A1 (en) * 2002-07-25 2004-01-29 Masters James G. Oral composition providing enhanced oral hygiene properties
US20040180110A1 (en) * 2003-03-14 2004-09-16 Atul Mistry Chewing gum and confectionery compositions containing an endothermic agent
DK1663168T3 (da) * 2003-09-08 2009-06-08 Mcneil Ab Nikotinformuleringer og anvendelse deraf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103099308A (zh) * 2012-11-13 2013-05-15 苏州谷力生物科技有限公司 一种改性糊精烟用保润剂的制备方法

Also Published As

Publication number Publication date
AR066584A1 (es) 2009-09-02
EP2152313A1 (en) 2010-02-17
CN101795710A (zh) 2010-08-04
EP2152313A4 (en) 2013-08-07
WO2008140371A1 (en) 2008-11-20
JP2010526875A (ja) 2010-08-05
NZ580732A (en) 2012-05-25
AU2008251095B2 (en) 2013-01-31
RU2009146576A (ru) 2011-06-27
RU2465904C2 (ru) 2012-11-10
ZA200908960B (en) 2011-02-23
EP2152313B1 (en) 2014-09-03
US20080286340A1 (en) 2008-11-20
KR20100017820A (ko) 2010-02-16
AU2008251095A1 (en) 2008-11-20
CA2685452A1 (en) 2008-11-20
BRPI0811110A2 (pt) 2014-12-09

Similar Documents

Publication Publication Date Title
MX2009012485A (es) Formulacion oral de nicotina amortiguada con aminoacidos.
CY1119764T1 (el) Φαρμακευτικο προϊον για ενδοστοματικη χορηγηση νικοτινης το οποιο περιλαμβανει τρομεταμολη ως ρυθμιστικο παραγοντα
MX2009012484A (es) Formulacion de nicotina oral recubierta regulada con aminoacido.
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
PH12015500301B1 (en) A novel formulation of diclofenac
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX354702B (es) Metodo de produccion de niveles fisiologicos y terapeuticos de oxido nitrico por medio de un sistema de suministro oral.
EA201100305A1 (ru) Лечение респираторных заболеваний
NZ595903A (en) A novel formulation of metaxalone
NZ702800A (en) Methods and compositions for cns delivery of heparan n-sulfatase
PH12016500746B1 (en) A novel formulation of meloxicam
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
WO2012001074A3 (en) Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
MX2009012109A (es) Composiciones contra el insomnio y metodos.
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
NZ595046A (en) Compositions and methods for extended therapy with aminopyridines
MX2009012486A (es) Una formulacion liquida para administrar nicotina.
WO2006100595A3 (en) Chewing gum compositions of varenicline
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2015066664A3 (en) Compositions and methods for administration of an enzyme to a subject's airway

Legal Events

Date Code Title Description
FG Grant or registration